Annual Accounts Payable
$4.42 M
+$2.28 M+106.54%
December 31, 2023
Summary
- As of February 25, 2025, CTCX annual accounts payable is $4.42 million, with the most recent change of +$2.28 million (+106.54%) on December 31, 2023.
- During the last 3 years, CTCX annual accounts payable has risen by +$3.55 million (+406.97%).
- CTCX annual accounts payable is now at all-time high.
Performance
CTCX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.21 M
+$118.90 K+2.90%
September 30, 2024
Summary
- As of February 25, 2025, CTCX quarterly accounts payable is $4.21 million, with the most recent change of +$118.90 thousand (+2.90%) on September 30, 2024.
- Over the past year, CTCX quarterly accounts payable has dropped by -$13.58 million (-76.31%).
- CTCX quarterly accounts payable is now -76.31% below its all-time high of $17.79 million, reached on September 30, 2023.
Performance
CTCX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTCX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +106.5% | -76.3% |
| 3 y3 years | +407.0% | +97.0% |
| 5 y5 years | +407.0% | +97.0% |
CTCX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +407.0% | -76.3% | +97.0% |
| 5 y | 5-year | at high | +407.0% | -76.3% | +97.0% |
| alltime | all time | at high | +407.0% | -76.3% | +97.0% |
Carmell Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.21 M(+2.9%) |
| Jun 2024 | - | $4.10 M(-4.4%) |
| Mar 2024 | - | $4.28 M(-3.0%) |
| Dec 2023 | $4.42 M | $4.42 M(-75.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $17.79 M(+531.9%) |
| Jun 2023 | - | $2.82 M(+31.6%) |
| Dec 2022 | $2.14 M(+145.5%) | $2.14 M |
| Dec 2021 | $871.30 K | - |
FAQ
- What is Carmell Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Carmell Therapeutics?
- What is Carmell Therapeutics annual accounts payable year-on-year change?
- What is Carmell Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly accounts payable year-on-year change?
What is Carmell Therapeutics annual accounts payable?
The current annual accounts payable of CTCX is $4.42 M
What is the all time high annual accounts payable for Carmell Therapeutics?
Carmell Therapeutics all-time high annual accounts payable is $4.42 M
What is Carmell Therapeutics annual accounts payable year-on-year change?
Over the past year, CTCX annual accounts payable has changed by +$2.28 M (+106.54%)
What is Carmell Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CTCX is $4.21 M
What is the all time high quarterly accounts payable for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly accounts payable is $17.79 M
What is Carmell Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CTCX quarterly accounts payable has changed by -$13.58 M (-76.31%)